CCR4 and adult T-cell leukemia/lymphoma: Among these receptors, CCR4 has been studied most intensively because of the association between predominant CCR4 expression on ATLL cells with skin involvement and unfavorable outcome [88,89], CCR4 has been successfully tested as a target for immunotherapy in ATLL in a phase I study [90,91].